Market technician Jonathan Krinsky analyzes the shift in market leadership from technology to healthcare amid recent ...

BTIG initiated coverage of Arcturus Therapeutics (ARCT) with a Buy rating and $41 price target Arcturus is a commercial-stage biotechnology ...

Personalis, Inc. (Nasdaq: PSNL), a leader in advanced genomics for precision oncology, announced today that its management team will be attending the ...

BTIG research firm reiterated its Buy rating and $21.00 price target for INmune Bio Inc. (NASDAQ:INMB), currently trading at ...

(Nasdaq: LFMD), a leading provider of virtual primary care services, today announced its participation in the 12 th Annual BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference ...

Delcath Systems, Inc. (Nasdaq: DCTH), an interventional oncology company focused on the treatment of primary and metastatic cancers of the liver, toda ...

What damage might Monday's ongoing selloff do to the technical set-up for stocks? Well, in a note published on Sunday, BTIG chartist guru Jonathan Krinsky observed that Friday's action had already sug ...

BTIG raised the firm’s price target on Intuitive Surgical (ISRG) to $622 from $561 and keeps a Buy rating on the shares after ...

BTIG analysts began covering Arcturus Therapeutics (NASDAQ:ARCT) with a positive outlook, assigning a Buy rating and establishing a price target of $41.00. Currently trading at $16.49 with a market ...

Papa Johns’ blueprint under CEO Todd Penegor has several targets, from a return to core strength focus to data leverage to ...

On Monday, Instacart (CART) stock saw a decline, ending the day at $45.65 which represents a decrease of $-0.34 or -0.74% from the prior close of $45.99. The stock opened at $45.17 and touched a low ...

The S&P 500 advanced 0.92% to 6,067.70, with technology shares seeing the biggest gains among sectors. The Technology Select ...